ArticleCancer chemotherapy and pharmacology2023

Adavosertib (AZD1775) does not prolong the QTc interval in patients with advanced solid tumors: a phase I open-label study.

Mats Någård et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.